New York, NY (December 10, 2022) — A new therapy that forces the immune system to kill bone marrow cancer cells has been successful in up to 73% of patients in two clinical trials, according to researchers from the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The therapy, known as …
Experimental Cancer Therapy Shows Over 70% Patient Success in Global Clinical Trials Read More »
WASHINGTON, Kansas, Dec 9 (Reuters) – Emergency crews prepared on Friday to work through the weekend to clean up the largest U.S. crude oil spill in nearly a decade, with workers descending into this farming community as far away as Mississippi. A strong smell of oil wafted through the air, a Reuters witness said, as …
Investigators and cleanup crews begin cleaning up oil pipeline spill in Kansas Read More »
A cancer-focused biotech company has sued eight of America’s biggest traders, including Citadel Securities, Susquehanna and Virtu, alleging they deliberately depressed its stock price by placing sell orders they didn’t have not intend to perform. The lawsuit, filed Thursday by Northwest Biotherapeutics in federal court in New York, alleged that marketers “deliberately engaged in repeated …
Cancer drug company accuses U.S. market makers of stock usurpation Read More »
